Logo image of SRE

SEMPRA (SRE) Stock Analyst Ratings

USA - NYSE:SRE - US8168511090 - Common Stock

91.14 USD
-1.15 (-1.25%)
Last: 10/16/2025, 8:16:12 PM
91.13 USD
-0.01 (-0.01%)
After Hours: 10/16/2025, 8:16:12 PM
Buy % Consensus

71

ChartMill assigns a Buy % Consensus number of 71% to SRE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 87.3. This target is -4.21% below the current price.
SRE was analyzed by 16 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about SRE.
In the previous month the buy percentage consensus was at a similar level.
SRE was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
SRE Historical Analyst RatingsSRE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -106 -96 -86 -76 -66 -56 -46 -36 -26 -16 -6 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 91.1477.1984.1587.3099.75 - -15.30% -7.67% -4.21% 9.45%
SRE Current Analyst RatingSRE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-10-07 Evercore ISI Group Initiate Outperform
2025-09-25 BMO Capital Maintains Outperform -> Outperform
2025-09-24 Mizuho Maintains Outperform -> Outperform
2025-09-24 Morgan Stanley Maintains Overweight -> Overweight
2025-08-26 Barclays Maintains Equal-Weight -> Equal-Weight
2025-08-04 Citigroup Maintains Neutral -> Neutral
2025-07-10 Barclays Maintains Equal-Weight -> Equal-Weight
2025-06-18 Morgan Stanley Maintains Overweight -> Overweight
2025-05-12 BMO Capital Maintains Outperform -> Outperform
2025-04-15 Jefferies Maintains Hold -> Hold
2025-04-09 Citigroup Maintains Neutral -> Neutral
2025-03-26 Wells Fargo Maintains Overweight -> Overweight
2025-03-20 Morgan Stanley Maintains Overweight -> Overweight
2025-03-04 BMO Capital Maintains Outperform -> Outperform
2025-03-03 Jefferies Downgrade Buy -> Hold
2025-02-27 Barclays Downgrade Overweight -> Equal-Weight
2025-02-26 Mizuho Maintains Outperform -> Outperform
2025-02-26 Guggenheim Maintains Buy -> Buy
2025-02-26 UBS Downgrade Buy -> Neutral
2025-02-26 Wells Fargo Maintains Overweight -> Overweight
2025-02-26 Goldman Sachs Downgrade Buy -> Neutral
2025-02-26 Morgan Stanley Maintains Overweight -> Overweight
2025-01-27 Barclays Maintains Overweight -> Overweight
2024-12-13 Morgan Stanley Upgrade Equal-Weight -> Overweight
2024-12-02 Barclays Maintains Overweight -> Overweight
2024-11-07 Wells Fargo Maintains Overweight -> Overweight
2024-11-07 Evercore ISI Group Maintains Outperform -> Outperform
2024-10-24 Jefferies Initiate Buy
2024-10-21 BMO Capital Maintains Outperform -> Outperform
2024-10-01 Barclays Maintains Overweight -> Overweight